Business Wire

GSMA Announces New Events and Programmes Taking Place at Mobile World Congress Shanghai 2018

Share

The GSMA today provided further details on the array of events and programmes that will be available to attendees at the 2018 GSMA Mobile World Congress Shanghai, including partner and co-located events; GSMA Forums, Seminars and Workshops; and Partner Programmes. Mobile World Congress Shanghai will be held 27-29 June at the Shanghai New International Expo Centre (SNIEC).

“We’ve expanded the number of programmes and events at Mobile World Congress Shanghai, featuring everything from sports and fitness to service robots to the intersection of art and innovation, and beyond,” said Michael O’Hara, Chief Marketing Officer, GSMA. “We have a very exciting event lined up and we are looking forward to bringing the mobile world together in Shanghai next month.”

New Details on Partner and Co-located Events at Mobile World Congress Shanghai

The GSMA today provided an update on the partner and co-located events that will be held concurrently with Mobile World Congress Shanghai, offering attendees a wide range of experiences.

Migu Health and Fitness Festival

Held 27-29 June in Hall W4 at the SNIEC, the Migu Health and Fitness Festival comprises a broad set of sports programmes and activities, all with a technology connection. Among the activities is the Charity Walk Challenge, in which the China Mobile Charity Foundation will donate funds matching the number of kilometres walked by Challenge participants. The donations will be used to aid students from impoverished areas in China. For more information on the Migu Health and Fitness Festival, visit: www.mwcshanghai.com/experiences/migu-health-fitness-festival/.

2018 Shanghai International Service Robot Show

The 2018 Shanghai International Service Robot Show will be held concurrently with Mobile World Congress Shanghai at the SNIEC in Hall N1. Established in 2015, the event is hosted by the China Service Robotics Industry Alliance and Caiqi Culture Communication (Shanghai) Co. Ltd. and co-organised by the Robotics Industry Technology Innovation Strategic Alliance of Ministry of Science and Technology. The event will demonstrate applications of service robots across a range of industries. The China International Child Intelligent Technology and Educational Robot Show will also take place in the same venue. For more information about the two shows, visit: www.en.srshow.cn.

Display China 2018

Display China will be co-located with Mobile World Congress Shanghai 27-29 June at the SNIEC. Mobile World Congress Shanghai attendees holding VIP, Gold, All Exhibition or Press/Analyst Passes will have access to Display China 2018. For more information about Display China, visit: http://en.srshow.cn.

New Exhibitors, Sponsors Confirmed for MWC Shanghai Show Floor

The first S-Nova Award will be presented during Mobile World Congress Shanghai, with finalists showcased at the SNIEC. Established by Association Des Jeunes Artistes Franco-Chinois (AJAFC), the S-Nova Award is a global award that recognises innovation at the intersection of art and technology fields and seeks to create business opportunities in these areas. The shortlisted entries for the Award will be showcased at stand D01 in Hall N5 during the event. For more information about the Award, visit: www.mwcshanghai.com/experiences/s-nova-award/ .

Newly confirmed exhibitors and sponsors for Mobile World Congress Shanghai include Ant Finance, AT&T, Canalys, Lenovo, PwC, Synchronoss, Tata Communications and Vodafone, among others. For more information on the exhibition, visit www.mwcshanghai.com/exhibition/2018-exhibitors/.

GSMA Forums, Seminars and Workshops

The GSMA will host a number of forums, seminars and workshops at Mobile World Congress Shanghai to share the latest developments in key industry programmes and advocacy initiatives. Currently scheduled GSMA programmes include:

  • Industrial Internet Workshop, organised by the GSMA and Alliance of Industrial Internet (Wednesday, 27 June, NEXTech Theatre, Hall W5, SNIEC)
  • 3rd Annual 5G Spectrum and Policy Workshop (Thursday, 28 June, Jumeirah Hotel)
  • Future Broadband Forum, organised by the GSMA and C114, sponsored by Hengtong, Nokia and Zhongtian (Thursday, 28 June, Kerry Hotel)
  • Data Protection and Privacy Policy Workshop (Thursday, 28 June, Jumeirah Hotel)
  • eSIM Workshop (Friday, 29 June, Hall N5-M50, SNIEC)

For more information on GSMA Forums, Seminars and Workshops, visit: www.mwcshanghai.com/conference-programmes/forums-seminars/.

New Partner Programmes in Shanghai

Mobile World Congress Shanghai will feature a range of partner programmes developed by leading players from across the mobile ecosystem. The 42nd Asia Pacific Mobile Operators Conference, sponsored by CLX Communications, MessageBird, SAP Asia, Syniverse Technologies and WIT Software, will be held on Monday, 25 June at the Kerry Hotel. Huawei will host six events from Tuesday, 26 June through Thursday, 28 June, while China Unicom will host its partner programme on Tuesday, 26 June. The GTI Summit Shanghai 2018 will take place on Wednesday, 27 June and Tata Communications will also run a workshop on that date. On Thursday, 28 June, the 5G Automotive Association and Vodafone will each host events. For more information about the Partner Programmes, visit: www.mwcshanghai.com/conference-programmes/partner-programmes/.

Get Involved at Mobile World Congress Shanghai 2018

For more information on Mobile World Congress Shanghai, including how to attend, exhibit, partner or sponsor, visit www.mwcshanghai.com. Follow developments and updates on Mobile World Congress Shanghai through our social media channels – follow us on Twitter at @GSMA and use #MWCS18, get regular updates through our LinkedIn Showcase Page at www.linkedin.com/company/mobile-world-congress-shanghai, and follow us on Facebook at www.facebook.com/mwcshanghai. In China, you can follow us on Sina Weibo weibo.com/mwcshanghai or search “GSMA_MWCS” in WeChat.

-ENDS-

About the GSMA

The GSMA represents the interests of mobile operators worldwide, uniting nearly 800 operators with more than 300 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces industry-leading events such as Mobile World Congress, Mobile World Congress Shanghai, Mobile World Congress Americas and the Mobile 360 Series of conferences.

For more information, please visit the GSMA corporate website at www.gsma.com. Follow the GSMA on Twitter: @GSMA.

Contact information

GSMA
Media Contacts:
For the GSMA
Ava Lau
+852 2533 9928
alau@webershandwick.com
or
Beau Bass
+44 79 7662 4962
beau.bass@webershandwick.com
or
GSMA Press Office
pressoffice@gsma.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FDA Approves OTEZLA® (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease19.7.2019 17:59:00 CESTPress release

Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has approved OTEZLA® (apremilast) 30 mg twice daily (BID) for the treatment of adult patients with oral ulcers associated with Behçet’s Disease. OTEZLA, an oral, selective inhibitor of phosphodiesterase 4 (PDE4), is the first and only approved treatment option for oral ulcers associated with Behçet’s Disease, a rare, chronic, multisystem inflammatory disease that is difficult to treat. “Oral ulcers are a recurring and debilitating manifestation that affects nearly everyone living with Behçet’s Disease, and have an important negative impact on the quality of life for these patients,” said Yusuf Yazici, M.D., Clinical Associate Professor, Department of Medicine, New York University Langone Health. “In the clinical trial, OTEZLA demonstrated improvements in measures of oral ulcers at week 12. OTEZLA has the potential to be a needed treatment option for U.S. patients and their physicians, who

Abiraterone Acetate Included in World Health Organisation’s Essential Medicines List for the Treatment of Metastatic Castration-Resistant Prostate Cancer19.7.2019 13:05:00 CESTPress release

The Janssen Pharmaceutical Companies of Johnson & Johnson is delighted with the recent announcement from the World Health Organisation (WHO) to include abiraterone acetate (ZYTIGA ® ) for the treatment of metastatic castration-resistant prostate cancer (mCRPC), in the updated Essential Medicines List, published on 9th July 2019.1,2 The WHO’s Essential Medicines List is a core guidance document that helps countries prioritise critical health products that are recommended to be widely available and affordable throughout health systems.1 “The inclusion of abiraterone acetate in the WHO Essential Medicines List highlights the critical role that this treatment can play in improving the lives of patients living with mCRPC and their families,” said Dr. Joaquín Casariego, Janssen Therapeutic Area Lead Oncology for Europe, Middle East & Africa, Janssen-Cilag S.A. “I am proud that we are working hard to impact survival and quality of life by developing and providing innovative medicines which ar

Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis19.7.2019 12:30:00 CESTPress release

Gilead Sciences, Inc. (NASDAQ: GILD) announced today that it has licensed three preclinical antiviral programs from Novartis, including investigational agents with the potential to treat human rhinovirus, influenza and herpes viruses. Under the agreement, Gilead will acquire exclusive global rights to develop and commercialize novel small molecules against three undisclosed targets. Novartis will receive an upfront payment and is eligible to receive up to an additional $291 million in potential milestone payments upon achievement of certain development and commercial milestones, as well as royalties on annual net sales. “Today’s announcement builds on Gilead’s heritage in antiviral research and development. We look forward to applying this expertise to advance the development of potential new treatments for viruses with limited therapeutic options,” said John McHutchison AO, MD, Gilead’s Chief Scientific Officer and Head of Research and Development. Gilead’s antiviral portfolio include

Schlumberger Announces Second-Quarter 2019 Results19.7.2019 11:00:00 CESTPress release

Schlumberger Limited (NYSE: SLB) today reported results for the second quarter of 2019. (Stated in millions, except per share amounts) Three Months Ended Change Jun. 30, 2019 Mar. 31, 2019 Jun. 30, 2018 Sequential Year-on-year Revenue $8,269 $7,879 $8,303 5% 0% Pretax segment operating income $968 $908 $1,094 7% -12% Pretax segment operating margin 11.7% 11.5% 13.2% 17 bps -148 bps Net income - GAAP basis $492 $421 $430 17% 14% Net income, excluding charges & credits* $492 $421 $594 17% -17% Diluted EPS - GAAP basis $0.35 $0.30 $0.31 17% 13% Diluted EPS, excluding charges & credits* $0.35 $0.30 $0.43 17% -19% North America revenue $2,801 $2,738 $3,139 2% -11% International revenue $5,463 $5,037 $5,065 8% 8% North America revenue, excluding Cameron $2,243 $2,178 $2,546 3% -12% International revenue, excluding Cameron $4,761 $4,469 $4,387 7% 9% *These are non-GAAP financial measures. See section titled "Charges & Credits" for details. Schlumberger Chairman and CEO Paal Kibsgaard commente

Schlumberger Appoints Olivier Le Peuch as CEO19.7.2019 10:46:00 CESTPress release

Schlumberger Limited (NYSE: SLB) announced today that its Board of Directors has appointed Olivier Le Peuch as its Chief Executive Officer and member of the Schlumberger Board, effective August 1, 2019. Mr. Le Peuch succeeds Paal Kibsgaard, who will retire as Chief Executive Officer effective that same date. Also effective August 1, Mr. Kibsgaard will step down as Chairman of the Board and retire as a member of the Board of Directors. Mr. Kibsgaard will retire after more than 22 years of service to the Company, including eight years as CEO and four years as Chairman. Effective the same date, Mark G. Papa, a current non-independent director, will become non-executive Chairman of the Board. Peter Currie will continue to serve as the Board’s Lead Independent Director. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190719005161/en/ Olivier Le Peuch is appointed Chief Executive Officer and a member of the Schlumberger Board, effe

Fluke Corporation Acquires Industrial Reliability Leader PRÜFTECHNIK19.7.2019 10:00:00 CESTPress release

Fluke Corp., the global leader in test and measurement instruments, has acquired Ismaning, Germany-based PRÜFTECHNIK, a market leader in precision laser shaft alignment, condition monitoring, and non-destructive testing. “Fluke’s acquisition of PRÜFTECHNIK reflects the growing importance our customers place on reliability systems to keep their equipment in optimum operating condition,” said Marc Tremblay, president of Fluke Corporation. “This business will help us usher in the next generation of solutions for our industrial customers.” Fluke Corporation For information on Fluke tools and applications, or to find the location of your nearest distributor, contact Fluke Corporation, P.O. Box 9090, Everett, WA USA 98206, call (800) 44-FLUKE (800-443-5853), fax (425) 446-5116, e-mail fluke-info@fluke.com or visit the Fluke Web site at http://www.fluke.com. About Fluke Founded in 1948, Fluke Corporation is the world leader in compact, professional electronic test tools and software for measu